Login / Signup

Safety and Tolerability of Paxlovid (Nirmatrelvir/Ritonavir) in High-risk Patients.

Bryan PeskoAlexandra DengJeannie D ChanSantiago NemeShireesha DhanireddyRupali Jain
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • randomized controlled trial
  • double blind